• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢素A通过损害白细胞介素1和白细胞介素2的释放来介导对原发性细胞毒性T细胞反应的免疫抑制。

Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

作者信息

Bunjes D, Hardt C, Röllinghoff M, Wagner H

出版信息

Eur J Immunol. 1981 Aug;11(8):657-61. doi: 10.1002/eji.1830110812.

DOI:10.1002/eji.1830110812
PMID:6456149
Abstract

The site of action of the immunosuppressive drug cyclosporin A in in vitro cytotoxic allograft responses has been localized. General cytotoxic effects of the drug on proliferating T cells became apparent at concentrations of 500-1000 ng/ml, while selective effects were observed at concentrations of 10-100 ng/ml. The selective effects included a blockade of interleukin 2 release from activated T helper cells on the one hand and inhibition of interleukin 1 release from splenic adherent cells on the other. While cyclosporin A did not interfere with the intracellular events required for the activation and subsequent clonal expansion of alloreactive T cells, the lack of interleukin 1 and interleukin 2 induced by cyclosporin A results in an inability of T responder cells to mount cytotoxic allograft responses in vitro.

摘要

免疫抑制药物环孢素A在体外细胞毒性同种异体移植反应中的作用位点已被定位。该药物对增殖T细胞的一般细胞毒性作用在浓度为500 - 1000纳克/毫升时变得明显,而在浓度为10 - 100纳克/毫升时观察到选择性作用。选择性作用一方面包括阻断活化的T辅助细胞释放白细胞介素2,另一方面包括抑制脾黏附细胞释放白细胞介素1。虽然环孢素A不干扰同种反应性T细胞活化及随后克隆扩增所需的细胞内事件,但环孢素A诱导的白细胞介素1和白细胞介素2的缺乏导致T反应细胞在体外无法引发细胞毒性同种异体移植反应。

相似文献

1
Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.环孢素A通过损害白细胞介素1和白细胞介素2的释放来介导对原发性细胞毒性T细胞反应的免疫抑制。
Eur J Immunol. 1981 Aug;11(8):657-61. doi: 10.1002/eji.1830110812.
2
Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.肿瘤启动子与钙离子载体共同作用,通过重新激活同种抗原致敏的小鼠T淋巴细胞来模拟抗原刺激。
J Immunol. 1985 Dec;135(6):3674-80.
3
Immunosuppressive effects of cyclosporin A on cloned T cells.环孢素A对克隆化T细胞的免疫抑制作用。
J Immunol. 1986 Feb 15;136(4):1315-21.
4
Analysis of cloned T cell function. I. Dissection of cloned T cell proliferative responses using cyclosporin A.克隆化T细胞功能分析。I. 使用环孢菌素A剖析克隆化T细胞的增殖反应。
J Immunol. 1982 Nov;129(5):1865-8.
5
IL-4 bypasses the immune suppressive effect of cyclosporin A during the in vitro induction of murine cytotoxic T lymphocytes.在体外诱导小鼠细胞毒性T淋巴细胞的过程中,白细胞介素-4可绕过环孢素A的免疫抑制作用。
J Immunol. 1988 Oct 1;141(7):2330-4.
6
Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors.白细胞介素4与白细胞介素2之间的协同作用在小鼠CD8细胞毒性T细胞前体的初次体外激活过程中赋予对环孢菌素A的抗性。
Eur J Immunol. 1989 Apr;19(4):625-30. doi: 10.1002/eji.1830190408.
7
Cyclosporine blocks the activation of antigen-dependent cytotoxic T lymphocytes directly by an IL-2-independent mechanism.环孢素通过一种不依赖白细胞介素-2的机制直接阻断抗原依赖性细胞毒性T淋巴细胞的激活。
J Immunol. 1988 May 15;140(10):3303-8.
8
Novel immunosuppressive agent, FK506. In vitro effects on the cloned T cell activation.新型免疫抑制剂FK506。对克隆化T细胞激活的体外作用。
J Immunol. 1987 Sep 15;139(6):1797-803.
9
Cyclosporin A inhibits IL 2-driven proliferation of human alloactivated T cells.环孢菌素A抑制白细胞介素2驱动的人同种异体活化T细胞的增殖。
J Immunol. 1986 Jun 1;136(11):4035-9.
10
Mechanism of action of cyclosporin A in vivo. I. Cyclosporin A fails to inhibit T lymphocyte activation in response to alloantigens.环孢素A在体内的作用机制。I. 环孢素A不能抑制T淋巴细胞对同种异体抗原的激活反应。
J Immunol. 1987 Dec 1;139(11):3597-603.

引用本文的文献

1
Fulminant Cardiac Sarcoidosis Successfully Treated With Aggressive Immunosuppressive Therapy.积极免疫抑制治疗成功治愈暴发性心脏结节病
Case Rep Cardiol. 2025 Mar 11;2025:1350557. doi: 10.1155/cric/1350557. eCollection 2025.
2
Understanding immunological insights of liver transplantation: a practice for attaining operational tolerance.理解肝移植的免疫学见解:实现手术耐受的实践。
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxae125.
3
Animal models for transplant immunology: bridging bench to bedside.移植免疫学的动物模型:从实验室到临床的桥梁。
Clin Transplant Res. 2024 Dec 31;38(4):354-376. doi: 10.4285/ctr.24.0029. Epub 2024 Sep 5.
4
Systemic Inflammatory Disorders, Immunosuppressive Treatment and Increase Risk of Head and Neck Cancers-A Narrative Review of Potential Physiopathological and Biological Mechanisms.系统性炎症疾病、免疫抑制治疗与头颈部癌症风险增加:潜在病理生理学和生物学机制的综述。
Cells. 2023 Sep 1;12(17):2192. doi: 10.3390/cells12172192.
5
Activated-memory T cells influence naïve T cell fate: a noncytotoxic function of human CD8 T cells.活化记忆性 T 细胞影响初始 T 细胞命运:人类 CD8 T 细胞的非细胞毒性功能。
Commun Biol. 2022 Jun 29;5(1):634. doi: 10.1038/s42003-022-03596-2.
6
Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells.通过靶向 B 细胞控制抗体介导的同种异体移植排斥反应的方法。
Front Immunol. 2021 Jul 1;12:682334. doi: 10.3389/fimmu.2021.682334. eCollection 2021.
7
Polymeric Micelles for the Enhanced Deposition of Hydrophobic Drugs into Ocular Tissues, without Plasma Exposure.用于将疏水药物增强沉积到眼组织中且不暴露于血浆的聚合物胶束。
Pharmaceutics. 2021 May 18;13(5):744. doi: 10.3390/pharmaceutics13050744.
8
Cyclosporin A aggravates hydrogen peroxide-induced cell death in kidney proximal tubule epithelial cells.环孢素A加重过氧化氢诱导的肾近端小管上皮细胞死亡。
Anat Cell Biol. 2019 Sep;52(3):312-323. doi: 10.5115/acb.18.192. Epub 2019 Aug 26.
9
Evaluation of Antigen-Specific IgM and IgG Production during an Peripheral Blood Mononuclear Cell Culture Assay.外周血单个核细胞培养试验期间抗原特异性 IgM 和 IgG 产生的评估。
Front Immunol. 2017 Jul 10;8:794. doi: 10.3389/fimmu.2017.00794. eCollection 2017.
10
Multicomponent High-throughput Drug Screening via Inkjet Printing to Verify the Effect of Immunosuppressive Drugs on Immune T Lymphocytes.喷墨打印高通量多组分药物筛选验证免疫抑制剂对免疫 T 淋巴细胞的作用
Sci Rep. 2017 Jul 24;7(1):6318. doi: 10.1038/s41598-017-06690-2.